Table 3.
Anti-ZIKV MNT seroconversions in samples collected in Mali, Senegal and The Gambia, by age group and sex (n, %, 95%CI).
| Study Site | Bamako, Mali n (%, 95% CI) |
Niakhar, Senegal n (%, 95% CI) |
Basse Santa Su, The Gambia n (%, 95% CI) |
|
|---|---|---|---|---|
| Age | 2–10 y | 0 (0.0, 0.0–4.35) |
1 (1.4, 0.03–7.30) |
0 (0.0, 0.0–4.45) |
| 11–17 y | 0 (0.0, 0.0–5.21) |
6 (8.0, 2.99–16.60) |
3 (4.5, 0.95–12.71) |
|
| 18–29 y | 1 (1.4, 0.04–7.81) |
1 (2.0, 0.05–10.85) |
3 (4.9, 1.03–13.71) |
|
| Sex | M | 1 (0.8, 0.02–4.48) |
5 (4.8, 1.58–10.86) |
5 (4.0, 1.31–9.09) |
| F | 0 (0.0, 0.0–3.66) |
3 (3.2, 0.66–9.04) |
1 (1.2, 0.03–6.53) |
|
| Total | 1 (0.5, 0.01–2.50) |
8 (4.0, 1.76–7.81) |
6 (2.9, 1.07–6.17) |
|